| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 07/22/1993 | CA2368862A1 Imidazole derivatives and their use as cytokine inhibitors |
| 07/22/1993 | CA2351694A1 Imidazole derivatives and their use as cytokine inhibitors |
| 07/22/1993 | CA2314425A1 Imidazole derivatives and their use as cytokine inhibitors |
| 07/22/1993 | CA2127540A1 Tie, a novel endothelial cell receptor tyrosine kinase |
| 07/22/1993 | CA2127532A1 Antibodies recognizing the fourth immunoglobulin-like domain of vcam1 |
| 07/22/1993 | CA2127246A1 A human kunitz-type protease inhibitor variant |
| 07/21/1993 | EP0552106A1 Peptide antagonists of bradykinin |
| 07/21/1993 | EP0552031A1 Oxepane isomers of rapamycin useful as immunosuppressive agents |
| 07/21/1993 | EP0551849A1 Novel arylcycloalkyl derivatives their production and their use |
| 07/21/1993 | EP0551662A1 Benzofuranyl- and thiophenylmethylthio-alcanecarboxylic acid derivatives |
| 07/21/1993 | EP0551400A1 Method for treating inflammation using anti-idiotypic antibodies |
| 07/21/1993 | EP0466730B1 Geminal bisphosphonic acids and derivatives as anti-arthritic agents |
| 07/20/1993 | US5229505 CNS and cardiovascular effects |
| 07/20/1993 | US5229405 Rheumatic diseases |
| 07/20/1993 | US5229403 Enzyme inhibitors, antiinflammatory |
| 07/20/1993 | US5229380 Method for treating helicobacter pylori gastritis |
| 07/20/1993 | US5229378 Antioxidant, antiinflammatory, antiallergen |
| 07/20/1993 | US5229367 Prostaglandin inhibitor, phospholipase inhibitor |
| 07/20/1993 | CA1320498C2 Methods and compositions for inhibiting lipoxygenase |
| 07/20/1993 | CA1320495C2 Optically active ketals, processes for their preparation and their use in the synthesis of alpha-arylakanoic acids |
| 07/20/1993 | CA1320492C Process for the preparation of novel 2-thienyl-oxyacetic acid derivatives |
| 07/20/1993 | CA1320490C Anti-inflammatory agents |
| 07/18/1993 | CA2087379A1 Pseudopeptidic derivatives having an antigonistic activity for bradykinine, process for their preparation and pharmaceutical compositions containing them |
| 07/14/1993 | EP0551230A1 Cyano-2-hydroxy-3-enamide derivatives, process for their preparation, their use as drugs, pharmaceutical compositions containing them and intermediates obtained |
| 07/14/1993 | EP0550807A2 Use of preparations of Curcuma plants |
| 07/14/1993 | EP0550668A1 Ibuprofen-antihistamine combinations |
| 07/14/1993 | EP0550502A1 Substituted imidazoles, their preparation and pharmaceutical compositions |
| 07/14/1993 | CN1074213A New derivative of tetrahydronaphthalene |
| 07/14/1993 | CA2086987A1 Benzofuranyl- and thiophenylmethylthio-alkanecarboxylic acid derivatives |
| 07/13/1993 | US5227389 Substituted 4-phenyl-4-piperidinecarboxamides with both local anaesthetic and analgesic effect as well as processes for their preparation |
| 07/13/1993 | CA1320201C 4,5,6-substituted-2-pyrimidinamines |
| 07/13/1993 | CA1320194C Substituted pyrroles |
| 07/13/1993 | CA1320131C Aqueous pharmaceutical preparation containing 11.beta.-hydroxy steroids |
| 07/08/1993 | WO1993013117A2 5- or 6-aminodeoxyfuranoside derivatives with antiinflammatory and antiproliferative activity |
| 07/08/1993 | WO1993013097A1 Anti-rheumatic naphthyridine derivatives |
| 07/08/1993 | WO1993013075A1 1-(arylalkyl-aminoalkyl)imidazole derivatives, processes of preparation and use as therapeutical agents |
| 07/08/1993 | WO1993012816A1 Monoclonal antibodies against type i phospholipase a2, used as a therapeutic agent to reduce inflammation |
| 07/08/1993 | WO1993012814A2 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 07/08/1993 | WO1993012808A1 A method for treating kaposi's sarcoma and blocking or inhibiting vascular permeability |
| 07/08/1993 | WO1993012654A1 Medical uses of trioxolane and diperoxide compounds |
| 07/08/1993 | CA2126757A1 Medical uses of trioxolane and diperoxide compounds |
| 07/08/1993 | CA2126686A1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 07/08/1993 | CA2126177A1 Therapeutic agents |
| 07/08/1993 | CA2126108A1 A method for treating kaposi's sarcoma and blocking or inhibiting vascular permeability |
| 07/08/1993 | CA2125858A1 Therapeutic agents |
| 07/08/1993 | CA2104477A1 Anti-proliferative and anti-inflammatory compounds: 5- 6-deoxy hexose monosaccharides having a saturated nitrogen-containing heterocycle at the 5- 6-position bound through the nitrogen atom |
| 07/07/1993 | EP0550337A1 Tissue protective tocopherol analogs |
| 07/07/1993 | EP0550292A1 Tissue protective tocopherol analogs |
| 07/07/1993 | EP0550083A1 Medicaments for treating imflammatory conditions or for analgesia containing a NSAID and canitidine bismuth citrate |
| 07/07/1993 | EP0550008A2 Use of N-acyl derivatives of aminoalcohols with polycarboxylic acids for the manufacture of a medicament for the treatment of pathologies relating to mast cells |
| 07/07/1993 | EP0550006A2 Use of N-acyl derivatives of aminoalcohols for the manufacture of a medicament for the treatment of pathologies involving mast cells |
| 07/07/1993 | EP0549797A1 Isoxazole compound, pharmaceutically acceptable salt thereof, and medicinal use thereof |
| 07/07/1993 | EP0549727A1 Carboxylic acid esters of rapamycin |
| 07/07/1993 | EP0549621A1 New leukotriene-b 4? antagonists, process for producing the same and their use as medicinal drugs. |
| 07/07/1993 | EP0549597A1 Anionic furanose derivatives, methods of making and using the same |
| 07/07/1993 | EP0412110B1 Novel vitamin d analogues |
| 07/07/1993 | EP0287633B1 Combinations of tumor necrosis factors and anti-inflammatory agents for treating malignant and non-malignant diseases |
| 07/06/1993 | US5225441 Treatment of periodontal disease |
| 07/06/1993 | US5225438 Aryl derivatives |
| 07/06/1993 | US5225422 Pyridine compounds which are useful as leukotriene b4 antagonist |
| 07/06/1993 | US5225420 Use of tetrahydrothienopyridine derivatives as angiogenesis inhibitors |
| 07/06/1993 | US5225206 Sustained-release pranoprofen preparation |
| 07/06/1993 | CA1319886C Mixed micelle solutions |
| 07/01/1993 | CA2086442A1 N-acyl derivatives of aminoalcohols active as local autocoidis and useful in the therapy of autoimmune processes |
| 07/01/1993 | CA2086441A1 N-acyl derivatives of aminoalcohols with polycarboxylic acids able to modulate mast cells in inflammatory processes having meuroimmunogenic origin |
| 06/30/1993 | EP0549267A1 Lip treatment composition |
| 06/30/1993 | EP0549073A1 Novel 2-saccharinylmethyl and 4,5,6,7-tetrahydro-2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 06/30/1993 | EP0548884A1 Biphosphonate derivative |
| 06/30/1993 | EP0548680A1 Beta-oxo-beta-benzenepropanethioamide derivatives |
| 06/30/1993 | EP0548291A1 Pyridylthio or pyridyloxy alkanoic acids |
| 06/30/1993 | EP0548226A1 Monosaccharides having anti-proliferation and anti-inflammatory activity, compositions and uses thereof |
| 06/30/1993 | EP0548168A1 Imidazole derivatives, their preparation and pharmaceutical compositions |
| 06/30/1993 | EP0548145A1 Topical treatment and composition |
| 06/30/1993 | EP0548125A1 Substituted 6,7-dihydroimidazo(1,5,4-ef)(1,5)benzodiazepin-6-ones, their preparation and pharmaceutical compositions |
| 06/30/1993 | EP0548123A1 Anti-inflammatory factor, method of isolation, and use |
| 06/30/1993 | CN1021444C Process for preparation of 16, 17-acetalsubstituted androstane-17 beta-carboxylic acid esters |
| 06/29/1993 | US5223538 Protecting cells against free radicals by treatment with hydroxamate-type siderophore chelate compounds and manganese compounds |
| 06/29/1993 | US5223537 Method and composition for treatment of gastric and duodenal disorders |
| 06/29/1993 | US5223533 Antiallergens, antiinflammatory, sunscreen agents |
| 06/29/1993 | US5223426 Monoclonal antibodies reactive with defined regions of the t-cell antigen receptor |
| 06/29/1993 | US5223425 DNA sequence which codes serine protease for diagnosis and/or treatment of obesity or metabolic defects |
| 06/29/1993 | CA1319695C Substituted 1,3,4,9-tetrahydropyrano¬3,4-b|- indole-1-acetic acids |
| 06/29/1993 | CA1319692C 2-methoxycarbonyl substituted n, n' -di-(trimethoxybenzoyl) piperazines, process for preparing the same and therapeutical compounds containing them |
| 06/29/1993 | CA1319616C Long-acting diclofenac sodium preparation |
| 06/29/1993 | CA1319607C Antithrombotic pharmaceutical preparation and process for preparing same |
| 06/28/1993 | CA2085427A1 2-saccharinylmethyl and 4,5,6,7-tetrahydro-2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of usethereof |
| 06/27/1993 | CA2086210A1 .beta.-oxo-.beta.-benzenepropanethioamide derivatives |
| 06/27/1993 | CA2086026A1 Bisphosphonate derivative |
| 06/24/1993 | WO1993012108A1 Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring |
| 06/24/1993 | WO1993012107A1 Imidazoylalkyl substituted with a six membered nitrogen containing heterocyclic ring |
| 06/24/1993 | WO1993012083A1 22-oxacholecalciferol derivative and production thereof |
| 06/24/1993 | WO1993012070A1 New tetrahydronaphthalene derivatives |
| 06/24/1993 | WO1993011794A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 06/24/1993 | WO1993011760A1 Aromatic esters of phenylenedialkanoates as inhibitors of human neutrophil elastase |
| 06/24/1993 | WO1993011745A1 Medicaments |
| 06/24/1993 | DE4142552A1 Monoklonale antikoerper gegen die typ i phospholipase a(pfeil abwaerts)2(pfeil abwaerts) als entzuendungshemmendes therapeutikum Monoclonal antibodies against type I phospholipase A (down arrow) 2 (down arrow) as therapeutic entzuendungshemmendes |
| 06/24/1993 | CA2126198A1 New tetrahydronaphthalene derivatives |
| 06/23/1993 | EP0548018A1 Imidazoles |
| 06/23/1993 | EP0548017A1 Thiazoles |
| 06/23/1993 | EP0547708A1 Saccharin derivative proteolytic enzyme inhibitors |